Development of Drugs Based on High-Polymeric Double-Stranded RNA for Antiviral and Antitumor Therapy
Authors:
- 1 October 2019
- journal article
- research article
- Published by Pleiades Publishing Ltd in Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry
- Vol. 13 (4) , 308-323
Abstract
—The review summarizes literature data on the development of drugs based on natural and synthetic high-polymeric double-stranded RNA (dsRNA), their antiviral, immunoadjuvant, and antitumor...Keywords
This publication has 105 references indexed in Scilit:
- Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and ImmunityImmunity, 2011
- Toll-like receptor 3, RIG-I-like receptors and the NLRP3 inflammasome: Key modulators of innate immune responses to double-stranded RNA virusesCytokine & Growth Factor Reviews, 2011
- LGP2 is a positive regulator of RIG-I– and MDA5-mediated antiviral responsesProceedings of the National Academy of Sciences, 2010
- Recognition of viral nucleic acids in innate immunityReviews in Medical Virology, 2009
- Induction of type I interferon by RNA viruses: cellular receptors and their substratesAmino Acids, 2009
- The TLR3 agonist poly(I:C) targets CD8+ T cells and augments their antigen-specific responses upon their adoptive transfer into naïve recipient miceVaccine, 2009
- Mechanism of Induction and Suppression of Antiviral Immunity Directed by Virus-Derived Small RNAs in DrosophilaCell Host & Microbe, 2008
- The response of mammalian cells to double-stranded RNACytokine & Growth Factor Reviews, 2007
- Activation of PKR: an open and shut case?Trends in Biochemical Sciences, 2007
- VISA Is an Adapter Protein Required for Virus-Triggered IFN-β SignalingMolecular Cell, 2005